Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial
Author:
Tamara S Hannon,Lily C Chao,Margarita Barrientos-Pérez,Karthik Chandrasekhar Pamidipati,Laura Fernández Landó,Clare J Lee,Hiren Patel,Brandon K Bergman
© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.